Page last updated: 2024-08-24

pyrrolidine dithiocarbamate and Focal Segmental Glomerulosclerosis

pyrrolidine dithiocarbamate has been researched along with Focal Segmental Glomerulosclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arias, SCA; Ávila, VF; Camara, NOS; Faustino, VD; Foresto-Neto, O; Fujihara, CK; Malheiros, DMAC; Zatz, R1

Other Studies

1 other study(ies) available for pyrrolidine dithiocarbamate and Focal Segmental Glomerulosclerosis

ArticleYear
Pathogenic role of angiotensin II and the NF-κB system in a model of malignant hypertensive nephrosclerosis.
    Hypertension research : official journal of the Japanese Society of Hypertension, 2019, Volume: 42, Issue:6

    Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Female; Glomerulosclerosis, Focal Segmental; Hypertension, Renal; Kidney Cortex; Kidney Glomerulus; Lactation; Losartan; Male; Nephrectomy; Nephritis; Nephrosclerosis; NF-kappa B; Pyrrolidines; Rats; Rats, Wistar; Thiocarbamates

2019